Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures

被引:63
作者
Alvesalo, J
Vuorela, H
Tammela, P
Leinonen, M
Saikku, P
Vuorela, P
机构
[1] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Fac Pharm, Div Pharmaceut Biol, FIN-00014 Helsinki, Finland
[3] Natl Publ Hlth Inst, FIN-90101 Oulu, Finland
[4] Univ Oulu, Dept Med Microbiol, FIN-90014 Oulu, Finland
关键词
Chlamydia pneumoniae; flavonoids; antichlamydial activity; phenolic compounds;
D O I
10.1016/j.bcp.2005.12.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chlamydial infections are very common worldwide. All chlamydial species have a tendency to cause persistent infections, which have been associated to several chronic diseases including blinding trachoma, infertility and coronary heart disease (CHD). At present, no efficient treatment for the eradication of chronic chlamydial infections exists and, thus, new antichlamydial compounds are urgently needed. This study was designed to screen antichlamydial activity of natural flavonoids and other natural and structurally similar synthetic compounds against Chlamydia pneumoniae in human cell line (HL). HL cells were infected with C. pneumoniae and incubated 72 h with studied compounds. Reduction in the number of inclusions was determined with immuno fluorescence staining. in vitro minimum inhibitory concentration was also determined for some of the most active compounds. Thirty seven percentage of the studied compounds (57 in total) were highly active against C. pneumoniae and all the studied compounds were non-toxic to the host cells at studied concentrations. Our study revealed direct antichlamydial effect for selected polyphenolic compounds against C. pneumoniae, in vitro. We also demonstrated the ability of some of the investigated compounds to accumulate inside cells or into cell membranes and cause inhibition, even when present only prior to infection. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:735 / 741
页数:7
相关论文
共 39 条
  • [1] DIETARY PHYTOESTROGENS AND CANCER - INVITRO AND INVIVO STUDIES
    ADLERCREUTZ, H
    MOUSAVI, Y
    CLARK, J
    HOCKERSTEDT, K
    HAMALAINEN, E
    WAHALA, K
    MAKELA, T
    HASE, T
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) : 331 - 337
  • [2] Effects of antibiotic therapy on outcomes of patients with coronary artery disease - A meta-analysis of randomized controlled trials
    Andraws, R
    Berger, JS
    Brown, DL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (21): : 2641 - 2647
  • [3] Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice
    Bin, XX
    Wolf, K
    Schaffner, T
    Malinverni, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1761 - 1764
  • [4] Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells
    Chen, D
    Daniel, KG
    Chen, MS
    Kuhn, DJ
    Landis-Piwowar, KR
    Dou, QP
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 69 (10) : 1421 - 1432
  • [5] Danesh J, 2005, LANCET, V365, P365
  • [6] DANNENFELSER R, 1989, COMPUT APPL BIOSCI, V5, P235
  • [7] Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis
    Dechend, R
    Maass, M
    Gieffers, J
    Dietz, R
    Scheidereit, C
    Leutz, A
    Gulba, DC
    [J]. CIRCULATION, 1999, 100 (13) : 1369 - 1373
  • [8] Infection and atherosclerosis - Emerging mechanistic paradigms
    Epstein, SE
    Zhou, YF
    Zhu, JH
    [J]. CIRCULATION, 1999, 100 (04) : E20 - E28
  • [9] A NEW RESPIRATORY-TRACT PATHOGEN - CHLAMYDIA-PNEUMONIAE STRAIN TWAR
    GRAYSTON, JT
    CAMPBELL, LA
    KUO, CC
    MORDHORST, CH
    SAIKKU, P
    THOM, DH
    WANG, SP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) : 618 - 625
  • [10] Chlamydia pneumoniae, asthma, and COPD:: what is the evidence?
    Hahn, DL
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (04) : 271 - +